March 2012
The essential resource for your practice
Volume XXI, Number 3

Medicare’s Ambulatory Surgical Center Quality Reporting Program

In the final CY 2012 payment rule for the Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Centers (ASCs), the Centers for Medicare & Medicaid Services (CMS) finalized its first pay-for-reporting quality program for ASCs, with reporting beginning October 1, 2012. see more>>

Table of Contents


Coding Corner:

Glitches in Medicare Programming for New NMP22 Code for 2012

AUA Applauds New Jersey for Legislation Supporting PSA Test

In January, the American Urological Association (AUA) applauded the New Jersey legislature for approving an act that opposes the U.S. Preventive Services Task Force (USPSTF) draft recommendations on the use of the prostate-specific antigen (PSA) test.

The act (AJR89/SJR77) asks “the Congress of the United States to seek the withdrawal of the United States Preventative Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.” The resolution was passed unanimously by both the Assembly (74-0) and the Senate (36-0) and signed by Governor Chris J. Christie (R). It was sponsored in the Assembly by late Republican Leader Alex DeCroce (R-26) and Joan M. Quigley (D-32) and in the Senate by Democratic Majority Leader Loretta Weinberg (D-37), Joseph F. Vitale (D-19) and Fred H. Madden (D-4). 

The AUA also expressed its sincere appreciation to David L. Taylor, MD, Chairman of the Board of the New Jersey Patient Care and Access Coalition (NJPCAC) and President of Garden State Urology in Morristown, NJ, for working with the New Jersey Legislature to pass this important legislation. The commitment of NJPCAC in leading more than 100 practicing urologists to educate policy makers and other key stakeholders on the issues affecting their profession and most importantly their patients is to be commended most heartily. see more>>

For The Record

Meaningful Use Measures: Monthly Discussion

Now that Stage 2 of Meaningful Use (MU) has been officially deferred, it seems appropriate to review the Stage 1 measures that more and more urology practices will endeavor to report in order to earn their share of the Medicare Electronic Health Records (EHR) Incentive program, referred to as “Meaningful Use.” Each month, we will dissect the requirements of a few of the measures. 

AUA Announces New Director of Government Relations & Advocacy

The Health Policy Division is pleased to announce that Sandie J. Preiss, MPA, has been appointed director of the Government Relations and Advocacy Department. 

She brings more than 25 years of senior level experience in government relations, healthcare policy, advocacy, political action committee development and coalition building to this position. For the past 17 years, Ms. Preiss served in senior level government relations and healthcare policy positions at Abbott Laboratories. Additionally, as a member of Abbott’s Government Relations department, Ms. Preiss has served in leadership positions for the Pharmaceutical Manufacturers Association and has an in-depth knowledge of Medicare, Medicaid and the implementation of the Affordable Care Act. see more>>